Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC)
Clinical trial NCT00084799 · COMPLETED
Trial details
- NCT number
- NCT00084799
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-26
- Primary completion
- 2006-01-25
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.